Methylene Blue

What It Is

A small-molecule phenothiazine compound studied as a mitochondrial electron carrier. At low concentrations, methylene blue accepts electrons from NADH and donates them to cytochrome c, providing an alternative electron-transfer route that researchers use to probe mitochondrial bioenergetics in models of mitochondrial dysfunction.

How It Works

Methylene blue concentrates in mitochondria

→

Reduced to leucomethylene blue by NADH

→

Donates electrons to cytochrome c

→

Bioenergetic pathways are studied under stress

What Researchers Study It For

Mitochondrial bioenergetics research

Cognitive function preclinical models

Tau aggregation pathway studies

Oxidative stress & antioxidant pathway research

Common Research Protocols

In published preclinical literature, methylene blue is typically administered orally or via injection at low mg/kg doses, with endpoints measured in brain tissue, behavioral task performance, and mitochondrial respiration markers. Hormetic dose-response curves are commonly reported — low concentrations behave differently than higher concentrations.

Community Interest Areas

The neurodegenerative research community has focused on methylene blue because it crosses the blood-brain barrier and can donate electrons distal to common mitochondrial complex defects — making it a useful probe for studying bioenergetic rescue in models of cognitive decline, tau pathology, and oxidative damage.

Low-Dose Hormetic dose-response in cognitive preclinical models

BBB Permeable Blood-brain barrier crossing established in pharmacokinetic literature

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.

What It Is

How It Works

What Researchers Study It For

Common Research Protocols

Community Interest Areas

What Are Peptides?

Are Peptides Safe?